Dyslipidemia (DL) is closely related to osteoporosis (OP), while the exact common genetic mechanisms are still largely unknown. We proposed to use novel genetic analysis methods with pleiotropic information to identify potentially novel and/ or common genes for the potential shared pathogenesis associated with OP and/or DL. We assessed the pleiotropy between plasma lipid (PL) and femoral neck bone mineral density (FNK BMD). We jointly applied the conditional false discovery rate (cFDR) method and the genetic analysis incorporating pleiotropy and annotation (GPA) method to the summary statistics provided by genome-wide association studies (GWASs) of FNK BMD (n = 49,988) and PL (n = 188,577) to identify potentially novel and/or common genes for BMD/PL. We found strong pleiotropic enrichment between PL and FNK BMD. Two hundred and forty-five PL SNPs were identified as potentially novel SNPs by cFDR and GPA. The corresponding genes were enriched in gene ontology (GO) terms "phospholipid homeostasis" and "chylomicron remnant clearance". Three SNPs (rs2178950, rs9939318, and rs9368716) might be the pleiotropic ones and the corresponding genes NLRC5 (rs2178950) and TRPS1 (rs9939318) were involved in NF-κB signaling pathway and Wnt signaling pathway as well as inflammation and innate immune processes. Our study validated the pleiotropy between PL and FNK BMD, and corroborated the reliability and high-efficiency of cFDR and GPA methods in further analyses of existing GWASs with summary statistics. We identified potentially common and/or novel genes for PL and/or FNK BMD, which may provide new insight and direction for further research.
Introduction
Osteoporosis (OP) is the most common metabolic bone disease, mainly characterized by low bone mineral density (BMD) and deterioration of bone microstructure (Philip and Cyrus 2006) . It is a major cause of osteoporotic fracture (OF) in the elderly (Philip and Cyrus 2006) . OF may occur with slight collision or even happen spontaneously and lead Communicated by S. Hohmann.
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to severe decrease of life quality, with increased morbidity, mortality, and disability (Porter and Bhimji 2017) . Only 33% of elderly women who suffered hip OF will be able to return to independence (Porter and Bhimji 2017) . OP is highly prevalent worldwide, over 200 million people suffer from OP (Sözen et al. 2017) . In USA, about 8 million women and 2 million men had OP in 2010 (Willson et al. 2015) . In China, the prevalence of OP ranged from 6.6 to 19.3% (Wang et al. 2009 ). Dyslipidemia (DL) is a condition with abnormal levels of plasma lipid (PL), including abnormally elevated levels of triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL), and descended levels of highdensity lipoprotein cholesterol (HDL) (Giner-Galvan et al. 2016) . The presence of DL increases the risk of suffering coronary heart disease (CHD) and future cardiovascular (CV) diseases (Fox et al. 2016) , which are ranked as the top two causes of premature death and decreased disabilityadjusted life-years (DALYs) worldwide (Murray et al. 2015) . In US, 36.7% adults were on or suit for lipid-lowing therapy during 2005 (Mercado et al. 2015 . In China, the prevalence of DL was 41.9% among adults (Huang et al. 2014) .
Experimental and clinical studies have demonstrated that DL is closely related to OP (Wong et al. 2016) . In clinic, patients with DL are often diagnosed with OP (Ibrahim et al. 2013) . A study with 279 either pre-or post-menopausal women demonstrated that high TC level was associated with low BMD (Jeong et al. 2014) . High cholesterol might influence cellular functions of bone tissue, such as increased osteoclast activity and decreased osteoblast function (Mandal 2015) . Bone metabolism and lipid metabolism might interact with each other by some molecules, such as osteoprotegerin (OPG) (Maser et al. 2015) , apolipoprotein E (APOE) (Singh et al. 2011) , peroxisome proliferatorsactivated receptor γ (PPARγ) (Ren et al. 2016) , and vitamin D receptor (VDR) (Hajj et al. 2016) . For example, OPG can reduce the production of osteoclasts and regulate the resorption of osteoclasts. Meanwhile, elevated OPG levels have been reported in heart diseases, which may be a link between bone and atherosclerosis-a main complication of DL (Maser et al. 2015) . Furthermore, medication for DL therapy, such as statins, can decrease PL and increase BMD simultaneously (Gotoh et al. 2011) .
OP and DL both are complex human diseases, which are affected by multiple genes. Both BMD and PL are highly heritable. For BMD, its heritability was about 50-80% (Videman et al. 2007) , and for PL, it was 40-60% (Asselbergs et al. 2012 ). The previous Genome-Wide Association Studies (GWASs) have identified about 200 loci associated with BMD and about 500 loci associated with PL (https://www. ebi.ac.uk/gwas, 1 Aug 2017). However, these identified single-nucleotide polymorphisms (SNPs) only explained a small part of the heritability. Further explorations were required for the missing heritability (Asselbergs et al. 2012; Richards et al. 2012) . Considering the multiple genes which might affect OP and DL as well as the high missing heritability, we would like to carry out more studies to explore the potentially novel genetic mechanisms and the potentially shared genetic relationship for OP and/or DL.
Novel pleiotropy informed analytical methods have emerged in recent years, such as conditional false discovery rate (cFDR), ccFDR (conjunction cFDR) (Andreassen et al. 2013) , and genetic analysis incorporating pleiotropy and annotation (GPA) (Chung et al. 2014) . These methods could incorporate summary statistics from independent GWASs to capture polygenic effects and identify more potentially novel loci for the interested phenotypes. Recently, Andreassen et al. have identified pleiotropy between BMD and PL, and found some novel BMD-associated SNPs conditioned on PL by cFDR method (Reppe et al. 2015) . Encouraged by their initial study, in this study, we will apply not only the cFDR method but also the complementary GPA method to larger and newer GWAS data sets of PL (Willer et al. 2013 ) and BMD (Zheng et al. 2015) . We hope to validate the pleiotropy between BMD and PL and identify potential common genes as well as potentially novel DL-associated genetic variants, with the results to be obtained from newer and larger data sets and with different analytical approaches for robustness. In our previous studies, we have successfully implemented cFDR analyses on GWAS data sets of femoral neck (FNK) BMD, height, birth weight, type 2 diabetes, and coronary artery disease (CAD), and identified potentially novel and pleiotropic genetic variants for these phenotypes simultaneously and, respectively, (Zeng et al. 2016; Greenbaum et al. 2017; Peng et al. 2017) . These experiences would contribute to better implementation of this study.
Materials and methods

GWAS data sets
We obtained GWAS results of FNK BMD and PL (HDL, LDL, TC, TG) in the form of summary statistic p values. FNK BMD GWAS data set contained more than 10 million SNPs from 49,988 subjects, and PL GWAS recruited 188,577 subjects and used GWAS array and Metabochip array to genotype/impute more than 2 million SNPs. Both data sets are the largest for FNK BMD and PL so far. FNK BMD data set was published online by genetic factors for osteoporosis (GEFOS) (http://www.gefos.org/), and PL data set was published by Global Lipids Genetics Consortium (GLGC) (http://csg.sph.umich.edu/abecasis/public/ lipids2013/). Detailed inclusion criteria and phenotype characteristics for the two GWASs were demonstrated in the original respective papers (Willer et al. 2013; Zheng et al. 2015) .
SNP pruning
We performed SNP pruning on FNK BMD and PL data sets, respectively, before further analysis. Since most of the individuals of the original GWASs were European ancestry, we used the CEU HapMap 3 genotype data for the SNP pruning. First, we merged common SNPs between FNK BMD and each kind of PL. After merging, there were about 2 million SNPs remained in each PL type. According to HapMap3 information, we calculated linkage disequilibrium (LD) values between each pair of SNPs by PLINK 1.9 software. We selected default value of the software (50, 5, 0.2) as parameters, which meant that the calculation of LD was performed in a window containing 50 SNPs. And the SNP in each pair with smaller minor allele frequency (MAF) was removed when the LD value (r 2 ) was greater than 0.2. Then, the calculation window slid forward with five SNPs and repeated the above process until no pairs of SNPs that were in high LD. After SNP merging and pruning, the remaining SNPs were prepared for subsequent analysis.
Statistical analysis
Pleiotropic enrichment estimation
We used "ggplot2" package in R software to construct foldenrichment plots to estimate the pleiotropic enrichment between FNK BMD and PL. The plots were formed by nominal -log 10 (p) values at different stratifications. Stratification was divided by p value of conditional phenotype with the cutoffs as p < 1 (expected base line, all SNPs), p < 0.1, p < 0.01 and p < 0.001. Nominal p values (− log 10 (p)) were plotted on x-axis and fold enrichments were plotted on y-axis. In each cut-off group, for all possible − log10 (p values) on the x-axis (between 0 and 10), we compute the fold-enrichment values:
where En is the enrichment values. N i is the proportion of SNPs with -log10 (p values) ≧ x. N 0 is the number of all SNPs in each cut-off group, and the i is from 1 to N 0 . The presence of pleiotropy can be visually observed as an upward shift from the expected base line. And there would be separation between different stratification. The greater separation indicated the stronger pleiotropy.As a complement for pleiotropic enrichment estimation, we performed a hypothesis testing procedure by GPA. In this testing, likelihood ratio
test (LRT) was used to assess statistical significance and show statistical evidence for pleiotropic enrichment. Here, we set threshold as p value = 0.05. We downloaded and ran "GPA" package in R software (http://dongjunchung.github. io/GPA/); then, we fit GPA model to test the hypothesis for pleiotropy.
Calculation of cFDR, ccFDR, and GPA
We set PL as the principal phenotype and FNK BMD as the conditional phenotype. Summary statistic p values of PL and FNK BMD GWAS data sets were incorporated by common SNPs for calculation of cFDR, ccFDR, and GPA. Detailed procedures and formulas were described by Greenbaum and Chung D, respectively (Chung et al. 2014; Greenbaum et al. 2017) . The cFDR method (Andreassen et al. 2013 ) was developed from standard FDR framework (Benjamini et al. 2001 ). The cFDR value represented a random SNP associated with PL conditioned on FNK BMD. In addition, ccFDR value referred to the possibility of a given SNP that had association with both FNK BMD and PL simultaneously. Both cFDR and ccFDR thresholds were set to 0.05, which meant that the SNP reached this threshold achieved significant association with the corresponding phenotype and the false discovery rate was 5%.
GPA method was performed by "GPA" package in R software. We fit a GPA model with summary statistic p values of SNPs and performed the analysis. fdr.GPA was used to represent the SNP that was associated with one of the two phenotypes, and fdr11.GPA was used to represent the SNP that was associated with both phenotypes. According to the criterion set in the original paper (Chung et al. 2014) , we adopted the same significance threshold of GPA to 0.2. Over this threshold meant that an SNP might not be associated with the corresponding phenotype.
Annotation of potentially novel SNPs for PL
If an SNP met the thresholds (cFDR < 0.05 and fdr. GPA < 0.2) for PL, we conferred it as a significant one. To verify whether the identified PL significant SNPs with p values > 5E−08 were potentially novel ones, we compared these SNPs to the other previous GWAS results by querying GWAS website (https://www.ebi.ac.uk/gwas, 1 Aug 2017). After comparison, we input non-repeat SNPs (including the significant SNPs with cFDR < 0.05, fdr. GPA < 0.2 and p values > 5E−8 in the original PL GWAS data set (Willer et al. 2013) , and the previously confirmed SNPs which were reported in the other PL GWASs) into the SNP Annotation and Proxy Search (SNAP, http:// archive.broadinstitute.org/mpg/snap/) for LD analysis. In the search options of the website, we chose suitable SNP data set and population panel based on the original GWASs (SNP data set was HapMap3 and population panel was CEU) for pairwise LD calculation. Then, we used the default values [r 2 threshold 0.8, distance limit 500, where distance means the maximum number of kilobase between query and proxy SNP (Johnson et al. 2008) ] as the criteria to determine whether the identified novel SNPs were in the same LD block with previous GWAS signals. Among these SNPs, only the SNP that had not been identified in other previous GWASs and was not clustered in the same LD block with those previously GWAS confirmed SNPs would be regarded as a potentially novel SNP; otherwise, it was regarded as a replication of the previous GWAS results.
Conditional and conjunction Manhattan plots
We used information including SNP number, chromosome position, and cFDR or ccFDR value to construct Manhattan plots by R software to visualize the localization of the significant SNPs (Figs. 2, 4) . The Manhattan plots consist of conditional and conjunction Manhattan plots, marking the significant SNPs and their chromosomal locations. In the conjunction Manhattan plot (Fig. 2) , the SNPs with significant -log 10 (ccFDR) values more than 1.3 (corresponding to a ccFDR value less than 0.05) were shown in the plot. Only those SNPs with fdr11.GPA less than 0.2 were highlighted with SNP numbers. These SNPs were defined as being associated with both phenotypes in the conjunction Manhattan plot. In the conditional Manhattan plot (Fig. 4) , the SNPs with -log 10 (cFDR) values more than 1.3 were determined as being associated with the principal phenotype.
Gene ontology enrichment analysis and proteinprotein interaction analysis of the identified SNPs and genes
We mapped the identified SNPs to corresponding genes by the online tool SNP and CNV Annotation Database (SCAN, http://scandb.org/newinterface/about.html). To evaluate the function of these genes and to partially validate our results, we performed Gene Ontology (GO) Enrichment analysis (http://geneontology.org/page/goenrichment-analysis). Meanwhile, using the online tool STRING 10.0 (http://string-db.org/), we further explored the functional interaction between the proteins produced by the corresponding genes. Protein-protein interaction analysis enabled us to identify the potential associations between the corresponding genes.
Results
Pleiotropy between FNK BMD and PL
As shown in fold-enrichment plots (Fig. 1) , each type of PL was the principal trait, while FNK BMD was the conditional trait. When restricting the subset of SNPs with a stronger level of association in the conditional trait, we observed an obvious upward shift from the expected base line. It well demonstrated the pleiotropy between FNK BMD and each type of PL (HDL|FNK BMD, LDL|FNK BMD, TC|FNK BMD, and TG|FNK BMD). Among the four plots, HDL conditioned on FNK BMD (HDL|FNK BMD) achieved the most significant pleiotropic enrichment, as a 9.5-fold enrichment was observed in Y-axis while comparing the most stringent subset to the all SNPs' subset (Fig. 1a) . LRT-p values acted as statistical evidence for pleiotropic enrichment through hypothesis testing of GPA and the results were presented in Table 1 . The pleiotropy between FNK BMD and HDL with an LRT-p value of 5.92E−03 was still the strongest, suggesting the highest level of pleiotropy between FNK BMD and HDL among all the PL traits.
Potentially pleiotropic SNPs/genes for both FNK BMD and PL
According to the thresholds of ccFDR < 0.05 a nd fdr11. GPA < 0.2, three SNPs (rs2178950, rs9939318 and rs9368716) were identified to be associated with both FNK BMD and PL (Fig. 2) . All the three SNPs' p values were higher than 5E−08 in the original FNK BMD and PL GWAS data sets. They were mapped to chromosomes 6, 8, and 16, and corresponded to C6orf10/LOC101929163, TRPS1, and NLRC5 genes, respectively (Table 2) . TRPS1 (rs2178950) gene was involved in autosomal dominant skeletal disorder, encoding a GATA-type transcription factor (Gai et al. 2011) . TRPS1 was associated with HDL and CAD in a meta-analysis of 46 GWASs of lipids (Teslovich et al. 2010) . NLRC5 (rs9939318) was a member of the NLR family. It acted as a transcriptional activator of MHC class I genes. Meanwhile, it contributed to inflammatory and type I interferon responses in vitro (Benko et al. 2017 ). According to protein-protein interaction information from "STRING Interaction Network" (Fig. 3) , we found these pleiotropic genes interacted with many other bone and/or PL-associated genes indirectly. For example, NLRC5 interacted with IKBKB, CHUK, DDX58, IFIH1, and RNF135, while TRPS1 interacted with JUN family and WDR family.
Potentially novel PL loci identified by cFDR and GPA
According to the thresholds of cFDR < 0.05 and fdr. GPA < 0.2, we identified totally 395 significant SNPs associated with PL variation conditioned on FNK BMD (Supplemental Table 1 ). Among the 395 SNPs, 144 SNPs achieved p values lower than 5E−8 in the original PL GWAS data sets (Willer et al. 2013 ), 1 SNP (rs12708980) in HDL was confirmed before to be GWAS-associated with PL (Kim et al. 2011) , and 5 SNPs had high LD values (according to the default value of the SNAP website, r 2 > 0.8) with the previous PL GWAS findings (Teslovich et al. 2010; Willer et al. 2013) , including 2 SNPs (rs5754467 and rs9930506) in HDL (Teslovich et al. 2010; Willer et al. 2013 ), 1 SNP (rs2699429) in LDL (Willer et al. 2013 ), 1 SNP (rs2178950) in TC (Teslovich et al. 2010) , and 2 SNPs (rs12751742 and rs9930506) in TG (Willer et al. 2013) (Table 3) . These SNPs were regarded as replications of the original PL GWAS. The remaining 245 SNPs with p values higher than genome-wide significance threshold of 5E-08 were potentially novel SNPs figure online) for PL, among which 71 SNPs were identified for HDL, 67 SNPs for LDL, 92 SNPs for TC, and 54 SNPs for TG (Table 3 ). These significant SNPs were mapped to 21 chromosomes (1-20, 22) and the positions were showed in the conditional Manhattan plots (Fig. 4) .
Gene annotation and function enrichment analysis for potentially novel PL SNPs
We mapped the 245 potentially novel SNPs to their corresponding genes by SCAN and performed the GO term enrichment analysis. The strongest enriched GO term and associated genes/SNPs for PL were listed in Table 4 . For HDL, the most enriched GO term was "phospholipid homeostasis", with a fold-enrichment value over 100 (p value = 6.53E-05). The significant genes in this GO term included HNF4A (rs2071197), LIPG (rs2097055, rs883218 and rs4556888), CETP (rs17369163), and GPAM (rs10787429). For TC, the most enriched GO term was "chylomicron remnant clearance", with fold enrichment as over 100 (p value = 2.12E−02). The significant genes in this GO term included LDLR (rs2738456), APOB (rs6733447), and LIPC (rs792902, rs1652519, rs6494007, rs4775046, and rs12324517). Both the most enriched GO terms play key roles in PL metabolism (Cabezas et al. 1993; Lim et al. 2011) . No enriched GO terms were found for LDL and TG. The other enriched GO terms were presented in Supplemental Table 2 .
Discussion
In this study, we combined the summary statistics from two independent GWAS data sets and jointly implemented cFDR and GPA methods to validate the pleiotropy between FNK BMD and PL (HDL, LDL, TC, and TG). Potentially common genes were identified between FNK BMD and PL, which could lead to a further and novel understanding of the shared genetic mechanisms for both OP and DL, and potentially have a positive impact on future clinical treatment and prevention. A number of potentially novel SNPs associated with PL were also identified, which provided new directions for future studies of molecular pathogenesis for DL.
To explore more missing heritability, the traditional ideas included recruiting more participants and genotyping larger samples, but these were difficult and impractical in many cases and costly. The advantages of cFDR and GPA methods were that they could leverage the power of pleiotropy using current GWAS data sets; they virtually increased the existing sample size and enhanced statistical power to explore more potential genetic variants. They also lessened the burden of multiple testing by controlling the false discovery rate, which meant that the cFDR and GPA methods could leverage pleiotropy information and also provide less conservative control of type I errors compared to Bonferroni correction (Shaffer 1995; Benjamini et al. 2001) . cFDR method was the first approach which statistically addressed the issue of pleiotropy between GWASs of two different traits based on Bayesian formula. GPA method could systematically integrate pleiotropy and annotate information based on LRT. In this study, if an SNP was identified by the two methods simultaneously, it meant that the SNP was validated virtually by two different approaches, which might further reduce false positive findings for more robust results. It should be noted that GPA method could be used to analyse GWAS results with or without annotation information. Meanwhile, summary statistic p values of GWAS were more important than functional annotation information in GPA (Chung et al. 2014) . Therefore, in this study, we chose not to use annotation information, which not only rendered efficient analysis in terms of computation but more importantly also matched the cFDR results better, since cFDR method could use only summary statistics information.
Andreassen et al. had identified pleiotropy between FNK BMD and PL by cFDR method in a previous study (Reppe et al. 2015) . They had identified 65 novel BMD loci by conditioning on cardiovascular disease (CVD)-related phenotypes, including PL (HDL, LDL, TC, and TG). Unlike their initial study, we hope to explore more relationships between FNK BMD and PL from different/novel aspects, such as to 1 3 Fig. 3 Protein-protein interaction networks for significant genes NLRC5 and TRPS1. a Genes interacted with NLRC5. B Genes interacted with TRPS1. Connections were based on evidence with "STRING Interaction Network Preview". Network nodes represented proteins produced by the corresponding genes. Edges between nodes indicated protein-protein associations. Edge color indicated the type of interaction and was specified on the bottom of the figure identify common genes to both PL and BMD, and novel PL-associated SNPs. These study aspects were not covered in the Andreassen's findings (Reppe et al. 2015) . Hence, on one hand, we validated the pleiotropy first. In our pleiotropic enrichment analysis, we used GPA method together with cFDR method based on larger and newer GWAS data sets and successfully validated the pleiotropy. We further quantified the degree of pleiotropy by enrichment plot and LRT. On the other hand, based on the validated pleiotropy, we focused on identifying potentially novel SNPs for PL conditioned on FNK BMD and identified common genes for FNK BMD and PL. These findings were novel compared to the Andreassen's results (Reppe et al. 2015) . By leveraging the pleiotropy, we could integrate PL and FNK BMD GWAS data sets and virtually increase the existing sample size. Then, we could use cFDR method and GPA method to enhance the statistical power to explore potentially novel PL-associated SNPs. In this study, we identified 395 significant SNPs for PL, of which 150 SNPs had reached p < 5E−8 in the original GWAS or were identified in other previous PL GWASs. These results reflected the reliability of the cFDR method and GPA method. Meanwhile, we identified 245 potentially novel SNPs for PL. Several genes corresponding to these potentially novel SNPs were enriched in plasma metabolism-related GO terms, such as "phospholipid homeostasis" and "chylomicron remnant clearance". This functional enrichment analysis result suggested that these potentially novel SNPs might be associated with PL metabolism.
We identified three pleiotropic SNPs (rs2178950, rs9939318, and rs9368716) that were associated with both FNK BMD and PL. rs2178950 was located in TRPS1. TRPS1 gene was confirmed to be associated with HDL in a previous GWAS meta-analysis (Teslovich et al. 2010) . Meanwhile, TRPS1 was associated with BMD (Gai et al. 2011 ) and Wnt signaling pathway (Fantauzzo and Christiano 2012) . Protein produced by TRPS1 was a transcription factor and played an important role in skeletal development by influencing osteoblast cell differentiation and osteocalcin expression (Piscopo et al. 2009 ). Deletion of TPRS1 could cause skeletal abnormalities called skeletal abnormalities of tricho-rhino-phalangeal syndrome type I, characterized by craniofacial abnormalities and disturbances in formation and maturation of bone matrix (de Barros and Kakehasi 2016) .
The pleiotropic SNP rs9939318 was located in NLRC5, which was related to inflammation and immunity (Benko et al. 2017) . Interestingly, PL was also involved in the pathological procedure of inflammation and immunity (Rao et al. 2015) . Cholesterol could induce immune response and inflammation during the progression of atherosclerosis (Rao et al. 2015) , and impact on the circulating monocytes and bone marrow (Bernelot Moens et al. 2017) . Therefore, we inferred that NLRC5 might be involved in DL through the process of inflammation and immunity. Meanwhile, NLRC5 could regulate bone mineralization by stimulating Wnt signal pathway to promote osteoblast differentiation , and it could also inhibit nuclear factor kappa B (NF-κB) (Benko et al. 2017 ) to decrease osteoclast. Wnt signaling could stimulate generation of osteoblasts by promoting mesenchymal stem cells (MSCs) towards osteoblast lineage, and decrease osteoclast differentiation by inducing OPG secretion and production (Manolagas 2014) . NF-κB is a transcriptional factor which regulates the bone-remodeling processes and inflammatory response in both bone resorption cells and bone forming (Benko et al. 2017 ). As mentioned above, NLRC5 was associated with OP through Wnt signal pathway ) and NF-κB (Benko et al. 2017) .
"STRING Interaction Network Analysis" offered information about protein-protein interaction and allowed us to explore the indirect interactions between genes. As shown in Fig. 3 , TRPS1 and NLRC5 were found to interact with many genes, such as IKBKB, CHUK, DDX58, IFIH1, RNF135, JUN family, and WDR family. Among them, IKBKB and CHUK were related to NF-κB, which was a regulating factor to the inflammatory response and bone-remodeling processes (Benko et al. 2017) . CHUK was an important paralog of IKBKB. The protein encoded by IKBKB phosphorylated the inhibitor in the NF-κB complex, causing activation of NF-κB. The encoded protein of CHUK was an inhibitor of the essential transcription factor NF-κB complex (Schmid and Birbach 2008; Solt and May 2008) . DDX58, IFIH1, and RNF135 were involved in pro-inflammatory cytokines and/ or immune system (Oshiumi et al. 2009; Ovsyannikova et al. 2010; Smyth et al. 2006 ). These information indicated that TRPS1 and NLRC5 might be the potential common genes associated with both OP and DL. NF-κB signaling pathway, Wnt signaling pathway, inflammation, and innate immune might be the shared mechanisms underlying the relationship between OP and DL.
Although we successfully improved the identification of potentially novel SNPs for PL and pleiotropic SNPs for PL and FNK BMD, there were still some limitations in our study. First, the contribution of our findings to the proportion of the phenotypes' variability could not be evaluated, since we only had access to summary statistics of GWAS without raw data to analyse. If we could get the raw genotype data in future, we are willing to perform linear regression with the novel SNPs and those earlier identified SNPs, so that we could analyse how much our findings would contribute to the whole heritability. Second, neither cFDR method nor GPA method had the ability to identify causal variants for the interested phenotype. The aim of our study was to identify more potentially novel SNPs and provide a new direction for further functional studies to be performed by molecular and cellular biologists; thus, follow-up studies should be conducted for replication and biological functional validation, and further elucidate the overall genetic mechanisms. However, under the experimental conditions of our group and time restriction, we could not carry out the functional validation experiments at present. We hope that this limitation could be partially addressed in the future by follow-up fine mapping studies and functional mechanistic studies of the GWAS-associated regions by our own and/ or other groups which are more specialized in functional studies. Meanwhile, considering the racial and population differences of heritability (Musani et al. 2017) , in the future, we could study other populations in the same way to identify the relationship between FNK BMD and PL among different populations.
In summary, by performing cFDR and GPA methods on current GWAS data sets, we validated pleiotropy between PL and FNK BMD and identified more potentially novel SNPs for PL. NLRC5 and TRPS1 might be the potentially common genes for PL and FNK BMD. NF-κB, Wnt, inflammation, and immune may be involved in the common pathogenesis of DL and OP. 
